VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)
VIEKIRA PAK is a brand-name prescription drug that’s FDA-approved to treat genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated cirrhosis. Brand Name: VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), co-packaged for oral use Initial U.S. Approval: 2014. FDA approved ombitasvir, paritaprevir, and ritonavir (brand name VIEKIRA PAK) is not (yet) registered or available in India but on request Indian patient can buy VIEKIRA PAK at the lowest price.
Home | (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets
Ombitasvir/paritaprevir/ritonavir is used together with dasabuvir or ribavirin for cases caused by hepatitis C virus genotype 1 or 4. Cure rates are around 95%. Ombitasvir/paritaprevir/ritonavir with dasabuvir was approved for medical use in the United States in 2014, and without dasabuvir in 2015.
VIEKIRA PAK with or without ribavirin is indicated for the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection including those with compensated cirrhosis. VIEKIRA PAK includes ombitasvir, a hepatitis C virus NS5A inhibitor, paritaprevir, a hepatitis C virus NS3/4A protease inhibitor, ritonavir, a CYP3A inhibitor and dasabuvir, a hepatitis C virus non-nucleoside NS5B palm polymerase inhibitor.
Ombitasvir/paritaprevir/ritonavir, sold under the brand name Technivie among others, is a medication used to treat hepatitis C. It is a fixed-dose combination of ombitasvir, paritaprevir, and ritonavir. The regimen ombitasvir-paritaprevir-ritonavir plus dasabuvir is FDA-approved for the treatment of chronic hepatitis C genotype 1, including those with compensated cirrhosis. The recommendations for use of the Viekira Pak refer to a dosing regimen of 2 tablets once daily of the fixed-dose combination ombitasvir-paritaprevir-ritonavir plus one tablet twice daily of dasabuvir. The regimen ombitasvir-paritaprevir-ritonavir plus dasabuvir is approved for use in both treatment-naive and treatment-experienced patients.
On December 19, 2014, the United States FDA approved ombitasvir-paritaprevir-ritonavir and dasabuvir for the treatment of genotype 1 chronic hepatitis C infection in adults, including patients with compensated cirrhosis. The medications ombitasvir, paritaprevir, and dasabuvir do not have FDA approval for use as individual drugs outside of use in the Viekira Pak. The drug ritonavir was previously approved by the FDA for use as an HIV protease inhibitor.
Drug (Brand / Generic):VIEKIRA PAK / ombitasvir, paritaprevir, and ritonavir
Current Indications: genotype 1 chronic hepatitis C virus (HCV) infection
Marketed by:: AbbVie Inc.
Approval Date: October 27, 2014
Available as (Form & Strength):
Tablets:
• Ombitasvir, paritaprevir, ritonavir: 12.5/75/50 mg
• Dasabuvir: 250 mg
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) ”. FDA approved ombitasvir, paritaprevir, and ritonavir (brand name VIEKIRA PAK) is not (yet) registered or available in India but on request Indian patient can buy VIEKIRA PAK at the lowest price. Confirmation of the order for VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to FDA approved ombitasvir, paritaprevir, and ritonavir (brand name VIEKIRA PAK) India.
For personal use, get access to FDA approved ombitasvir, paritaprevir, and ritonavir (brand name VIEKIRA PAK) India. On request, We have imported and delivered Anti-cancer medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
VIEKIRA PAK Sourcing & Delivery
Alleviare India specializes in sourcing and supplying VIEKIRA PAK , a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of VIEKIRA PAK in India.
How much does VIEKIRA PAK cost in the India?
Kindly reach out to us for VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import VIEKIRA PAK to India?
To import ombitasvir, paritaprevir, and ritonavir VIEKIRA PAK , patients or government hospitals can place an order on behalf of the patients.
The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is VIEKIRA PAK available in India?
VIEKIRA PAK ombitasvir, paritaprevir, and ritonavir is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of VIEKIRA PAK (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for VIEKIRA PAK availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is ombitasvir, paritaprevir, and ritonavir available in India?
Yes, FDA approved ombitasvir, paritaprevir, and ritonavir (brand name VIEKIRA PAK) is not (yet) registered or available in India but on request Indian patient can buy VIEKIRA PAK at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) . The import process requires a valid prescription and an Import License in the Patient’s Name.
